Browse Gene Sets

Gene set name:

 
  (Enter full or partial name)

By first letter:

 

1 2 3 4 5 6 7 8 9 0 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

By collection:

[about the MSigDB collections]

  • H (hallmark gene sets, 50 gene sets)
  • C1 (positional gene sets, 278 gene sets)
  • C2 (curated gene sets, 6290 gene sets)
    • CGP (chemical and genetic perturbations, 3368 gene sets)
    • CP (canonical pathways, 2922 gene sets)
  • C3 (regulatory target gene sets, 3731 gene sets)
    • MIR (microRNA targets, 2598 gene sets)
    • TFT (all transcription factor targets, 1133 gene sets)
      • TFT:GTRD (GTRD transcription factor targets, 523 gene sets)
      • TFT:TFT_Legacy (legacy transcription factor targets, 610 gene sets)
  • C4 (computational gene sets, 858 gene sets)
    • CGN (cancer gene neighborhoods, 427 gene sets)
    • CM (cancer modules, 431 gene sets)
  • C5 (ontology gene sets, 14998 gene sets)
    • GO (Gene Ontology, 10185 gene sets)
      • GO:BP (GO biological process, 7481 gene sets)
      • GO:CC (GO cellular component, 996 gene sets)
      • GO:MF (GO molecular function, 1708 gene sets)
    • HPO (Human Phenotye Ontology, 4813 gene sets)
  • C6 (oncogenic signature gene sets, 189 gene sets)
  • C7 (immunologic signature gene sets, 5219 gene sets)
    • IMMUNESIGDB (ImmuneSigDB gene sets, 4872 gene sets)
    • VAX (vaccine response gene sets, 347 gene sets)
  • C8 (cell type signature gene sets, 671 gene sets)

Gene sets starting with O

Click on a gene set name to view its gene set page.

OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_
70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_A
FTER_FIRST_DOSE_DN

OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_
70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_A
FTER_FIRST_DOSE_UP

OCT1_01
OCT1_02
OCT1_03
OCT1_04
OCT1_05
OCT1_06
OCT1_07
OCT1_B
OCT1_Q5_01
OCT1_Q6
OCT_C
OCT_Q6
ODONNELL_METASTASIS_DN
ODONNELL_METASTASIS_UP
ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
ODONNELL_TFRC_TARGETS_DN
ODONNELL_TFRC_TARGETS_UP
OHASHI_AURKA_TARGETS
OHASHI_AURKB_TARGETS
OHGUCHI_LIVER_HNF4A_TARGETS_DN
OHGUCHI_LIVER_HNF4A_TARGETS_UP
OHM_EMBRYONIC_CARCINOMA_DN
OHM_EMBRYONIC_CARCINOMA_UP
OHM_METHYLATED_IN_ADULT_CANCERS
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP
OKAWA_NEUROBLASTOMA_1P36_31_DELETIO
N

OKUMURA_INFLAMMATORY_RESPONSE_LPS
OLF1_01
OLSSON_E2F3_TARGETS_DN
OLSSON_E2F3_TARGETS_UP
ONDER_CDH1_SIGNALING_VIA_CTNNB1
ONDER_CDH1_TARGETS_1_DN
ONDER_CDH1_TARGETS_1_UP
ONDER_CDH1_TARGETS_2_DN
ONDER_CDH1_TARGETS_2_UP
ONDER_CDH1_TARGETS_3_DN
ONDER_CDH1_TARGETS_3_UP
ONGUSAHA_BRCA1_TARGETS_DN
ONGUSAHA_BRCA1_TARGETS_UP
ONGUSAHA_TP53_TARGETS
ONKEN_UVEAL_MELANOMA_DN
ONKEN_UVEAL_MELANOMA_UP
ONO_AML1_TARGETS_DN
ONO_AML1_TARGETS_UP
ONO_FOXP3_TARGETS_DN
ONO_FOXP3_TARGETS_UP
ORGAN_DEVELOPMENT
ORGANELLE_ENVELOPE
ORGANELLE_ORGANIZATION_AND_BIOGENES
IS

ORGANELLE_OUTER_MEMBRANE
OSADA_ASCL1_TARGETS_DN
OSADA_ASCL1_TARGETS_UP
OSAWA_TNF_TARGETS
OSF2_Q6
OSMAN_BLADDER_CANCER_DN
OSMAN_BLADDER_CANCER_UP
OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_H
IGH_DOSE_SUBJECTS_24HR_DN

OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_H
IGH_DOSE_SUBJECTS_24HR_UP

OSWALD_HEMATOPOIETIC_STEM_CELL_IN_C
OLLAGEN_GEL_DN

OSWALD_HEMATOPOIETIC_STEM_CELL_IN_C
OLLAGEN_GEL_UP

OUELLET_CULTURED_OVARIAN_CANCER_INV
ASIVE_VS_LMP_DN

OUELLET_CULTURED_OVARIAN_CANCER_INV
ASIVE_VS_LMP_UP

OUELLET_OVARIAN_CANCER_INVASIVE_VS_
LMP_DN

OUELLET_OVARIAN_CANCER_INVASIVE_VS_
LMP_UP

OUILLETTE_CLL_13Q14_DELETION_DN
OUILLETTE_CLL_13Q14_DELETION_UP
OUYANG_PROSTATE_CANCER_MARKERS
OUYANG_PROSTATE_CANCER_PROGRESSION_
DN

OUYANG_PROSTATE_CANCER_PROGRESSION_
UP

OVOL3_TARGET_GENES
OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74
YO_COMMON_WITH_BOTH_HAI_AND_VNA_28D
Y_VS_0DY_USED_IN_HAI_AND_VNA_RESPON
SE_MODELS_DN

OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74
YO_COMMON_WITH_BOTH_HAI_AND_VNA_28D
Y_VS_0DY_USED_IN_HAI_AND_VNA_RESPON
SE_MODELS_UP

OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74
YO_COMMON_WITH_BOTH_HAI_AND_VNA_28D
Y_VS_3DY_USED_IN_HAI_AND_VNA_RESPON
SE_MODELS_DN

OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74
YO_COMMON_WITH_BOTH_HAI_AND_VNA_28D
Y_VS_3DY_USED_IN_HAI_AND_VNA_RESPON
SE_MODELS_UP

OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64
YO_RESPONDERS_VS_NONRESPONDERS_0DY_
DN

OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64
YO_RESPONDERS_VS_NONRESPONDERS_0DY_
UP

OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64
YO_RESPONDERS_VS_NONRESPONDERS_28DY
_DN

OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64
YO_RESPONDERS_VS_NONRESPONDERS_28DY
_UP

OXFORD_RALA_AND_RALB_TARGETS_DN
OXFORD_RALA_AND_RALB_TARGETS_UP
OXFORD_RALA_OR_RALB_TARGETS_DN
OXFORD_RALA_OR_RALB_TARGETS_UP
OXFORD_RALA_TARGETS_DN
OXFORD_RALA_TARGETS_UP
OXFORD_RALB_TARGETS_DN
OXFORD_RALB_TARGETS_UP
OXIDOREDUCTASE_ACTIVITY_GO_0016616
OZANNE_AP1_TARGETS_UP
OZEN_MIR125B1_TARGETS